This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Aug 30;120(9):1754-6.

doi: 10.1182/blood-2012-06-434571.

Treating myeloma: the future is already here!

Ola Landgren¹, Neha Korde

Affiliations

PMID: 22936733
DOI: 10.1182/blood-2012-06-434571

Free article

Comment

Treating myeloma: the future is already here!

Ola Landgren et al. Blood. 2012.

Free article

. 2012 Aug 30;120(9):1754-6.

doi: 10.1182/blood-2012-06-434571.

Authors

Ola Landgren¹, Neha Korde

Affiliation

¹ National Cancer Institute, USA.

PMID: 22936733
DOI: 10.1182/blood-2012-06-434571

Erratum in

Blood. 2014 Mar 6;123(10):1621

No abstract available

PubMed Disclaimer

Comment on

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.
Jakubowiak AJ, Dytfeld D, Griffith KA, Lebovic D, Vesole DH, Jagannath S, Al-Zoubi A, Anderson T, Nordgren B, Detweiler-Short K, Stockerl-Goldstein K, Ahmed A, Jobkar T, Durecki DE, McDonnell K, Mietzel M, Couriel D, Kaminski M, Vij R. Jakubowiak AJ, et al. Blood. 2012 Aug 30;120(9):1801-9. doi: 10.1182/blood-2012-04-422683. Epub 2012 Jun 4. Blood. 2012. PMID: 22665938 Free PMC article. Clinical Trial.

Similar articles

Peripheral neuropathy in multiple myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (RVD) therapy.
Voorhees PM, Laubach J, Anderson KC, Richardson PG. Voorhees PM, et al. Blood. 2013 Jan 31;121(5):858. doi: 10.1182/blood-2012-11-465765. Blood. 2013. PMID: 23372151 Free PMC article. No abstract available.
Tandem bone marrow transplantation in multiple myeloma.
Musto P. Musto P. N Engl J Med. 2004 Apr 1;350(14):1466-7; author reply 1466-7. N Engl J Med. 2004. PMID: 15074004 No abstract available.
Multiple myeloma, 2004--one or two transplants?
Stadtmauer EA. Stadtmauer EA. N Engl J Med. 2003 Dec 25;349(26):2551-3. doi: 10.1056/NEJMe038187. N Engl J Med. 2003. PMID: 14695416 No abstract available.
Role of hematopoietic stem cell transplantation in multiple myeloma.
Garcia IN. Garcia IN. Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):86-91. doi: 10.1016/j.clml.2014.07.007. Epub 2014 Jul 14. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25131852 Review.
High-dose therapy in multiple myeloma.
Harousseau JL, Attal M. Harousseau JL, et al. Hematol J. 2003;4(3):163-70. doi: 10.1038/sj.thj.6200259. Hematol J. 2003. PMID: 12764348 Review. No abstract available.

See all similar articles

Cited by

Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.
Aouali N, Broukou A, Bosseler M, Keunen O, Schlesser V, Janji B, Palissot V, Stordeur P, Berchem G. Aouali N, et al. PLoS One. 2015 Jun 19;10(6):e0130339. doi: 10.1371/journal.pone.0130339. eCollection 2015. PLoS One. 2015. PMID: 26091518 Free PMC article.
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.
Cherry BM, Korde N, Kwok M, Manasanch EE, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Maric I, Calvo KR, Braylan R, Stetler-Stevenson M, Yuan C, Tembhare P, Zingone A, Costello R, Roschewski MJ, Landgren O. Cherry BM, et al. Leuk Lymphoma. 2013 Oct;54(10):2215-8. doi: 10.3109/10428194.2013.764419. Epub 2013 Jul 29. Leuk Lymphoma. 2013. PMID: 23311294 Free PMC article.
Improved long-term survival in multiple myeloma up to the age of 80 years.
Kristinsson SY, Anderson WF, Landgren O. Kristinsson SY, et al. Leukemia. 2014 Jun;28(6):1346-8. doi: 10.1038/leu.2014.23. Epub 2014 Jan 14. Leukemia. 2014. PMID: 24418994 No abstract available.
Peripheral neuropathy in multiple myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (RVD) therapy.
Voorhees PM, Laubach J, Anderson KC, Richardson PG. Voorhees PM, et al. Blood. 2013 Jan 31;121(5):858. doi: 10.1182/blood-2012-11-465765. Blood. 2013. PMID: 23372151 Free PMC article. No abstract available.
Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity.
Flanders A, Stetler-Stevenson M, Landgren O. Flanders A, et al. Blood. 2013 Aug 8;122(6):1088-9. doi: 10.1182/blood-2013-05-506170. Blood. 2013. PMID: 23929839 Free PMC article. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Medical
- MedlinePlus Health Information